Emons, G., Gorchev, G., Harter, P., Wimberger, P., Stähle, A., Hanker, L., Hilpert, F., Beckmann, M.W., Dall, P., Gründker, C., Sindermann, H. und Sehouli, J. (2014) „Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5)“, International journal of gynecological cancer, (Band 24, Heft 2 (2014), Seite 260-265), S. , Heft 2 (2014), Seite 260-265. doi:10.1097/IGC.0000000000000044.

Emons, Günter, Grigor Gorchev, Philipp Harter, Pauline Wimberger, Anne Stähle, Lars Hanker, Felix Hilpert, Matthias Wilhelm Beckmann, Peter Dall, Carsten Gründker, Herbert Sindermann, und Jalid Sehouli. „Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5)“. Electronic. International journal of gynecological cancer, Nr. Band 24, Heft 2 (2014), Seite 260-265 ([2014?]): , Heft 2 (2014), Seite 260-265. https://doi.org/10.1097/IGC.0000000000000044.

Emons, G., Gorchev, G., Harter, P., Wimberger, P., Stähle, A., Hanker, L., Hilpert, F., Beckmann, M. W., Dall, P., Gründker, C., Sindermann, H., & Sehouli, J. (ca. 2014). Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5) [Electronic]. International journal of gynecological cancer, Band 24, Heft 2 (2014), Seite 260-265, , Heft 2 (2014), Seite 260-265. https://doi.org/10.1097/IGC.0000000000000044

Emons, G., G. Gorchev, P. Harter, P. Wimberger, A. Stähle, L. Hanker, F. Hilpert, M. W. Beckmann, P. Dall, C. Gründker, H. Sindermann, und J. Sehouli. „Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5)“. International journal of gynecological cancer, electronic, Nr. Band 24, Heft 2 (2014), Seite 260-265, London : BMJ Publishing Group Ltd, 1991-, 2014, S. , Heft 2 (2014), Seite 260-265, https://doi.org/10.1097/IGC.0000000000000044.

EMONS, Günter, Grigor GORCHEV, Philipp HARTER, Pauline WIMBERGER, Anne STÄHLE, Lars HANKER, Felix HILPERT, Matthias Wilhelm BECKMANN, Peter DALL, Carsten GRÜNDKER, Herbert SINDERMANN und Jalid SEHOULI, 2014. Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : a multicenter phase 2 trial (AGO-GYN5). International journal of gynecological cancer. 2014. Nr. Band 24, Heft 2 (2014), Seite 260-265, S. , Heft 2 (2014), Seite 260-265. DOI 10.1097/IGC.0000000000000044